Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chongwu Li

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Lung Cancer (Amsterdam, Netherlands)|February 10, 2023
Utility of <sup>18</sup>F-FDG PET/CT uptake values in predicting response to neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancerFenghui Zhuang, E Haoran, Jia Huang, et al.
Signal Transduction and Targeted Therapy|August 31, 2023
Intestinal microbiota links to allograft stability after lung transplantation: a prospective cohort studyJunqi Wu, Chongwu Li, Peigen Gao, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 19, 2024
Predicting therapeutic response to neoadjuvant immunotherapy based on an integration model in resectable stage IIIA (N2) non-small cell lung cancerLong Xu, Haojie Si, Fenghui Zhuang, et al.
Cancer Immunology, Immunotherapy : CII|September 3, 2022
The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center studyChongwu Li, Junqi Wu, Long Jiang, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Lung Cancer (Amsterdam, Netherlands)|February 10, 2023
Utility of <sup>18</sup>F-FDG PET/CT uptake values in predicting response to neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancerFenghui Zhuang, E Haoran, Jia Huang, et al.
Signal Transduction and Targeted Therapy|August 31, 2023
Intestinal microbiota links to allograft stability after lung transplantation: a prospective cohort studyJunqi Wu, Chongwu Li, Peigen Gao, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 19, 2024
Predicting therapeutic response to neoadjuvant immunotherapy based on an integration model in resectable stage IIIA (N2) non-small cell lung cancerLong Xu, Haojie Si, Fenghui Zhuang, et al.
Cancer Immunology, Immunotherapy : CII|September 3, 2022
The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center studyChongwu Li, Junqi Wu, Long Jiang, et al.
Pageof 3